CNTX
Context TherapeuticsANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
CNTX vs peer average
91/100
CNTX vs. peer average (A vs. D)
Grade spread
A 2 · C 2 · D 4 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
FATE is the first available peer comparator.
Same-sector small-cap biotech comparator from the packet; relevant as a higher-profile clinical-stage risk-appetite check, but still too loose to support valuation or clinical read-through confidence.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
CNTX
Context Therapeutics
FATE
Fate Therapeutics
Grade
A
F
Momentum
99
21
Value
41
41
Sentiment
59
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs FATE
CNTX / FATE
Grade Position
Above peers
CNTX vs. peer average (A vs. D)
91/100
Momentum
99
CNTXValue
41
CNTXSentiment
59
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs CNTX
FATE is the first peer returned for this comparison set.